J. Matthew Singleton, Director: Viking Therapeutics VKTX Sell · Filed 24/09/20

Trade details

Type: Insider sale
Amount: $715,850
Shares · price: 10,300 sh · $69.50 a share
Held after: 9,500 sh
Stock: Viking Therapeutics VKTX
Person: J. Matthew SingletonDirector
Trade date: 24/09/20
Filed: 24/09/20
Days to filing: 0 days

Sold 52.0% of holdings

Share of holding sold: 52.0%

Viking Therapeutics trades, last 26 weeks

What else happened in Viking Therapeutics around then

Filed or reported within 30 days of the trade day · 24/08/21~24/10/20

J. Matthew Singleton's recent trades

J. Matthew SingletonDirector
Sell10b5-1 planViking Therapeutics
Sell10b5-1 plan
Viking Therapeutics
VKTX
$1.3M
16,000 sh
$1.3M
Filed 24/10/25
Traded 24/10/25
J. Matthew SingletonDirector
Sell10b5-1 planViking Therapeutics
Sell10b5-1 plan
Viking Therapeutics
VKTX
$397.4K
5,700 sh
$397.4K
Filed 24/08/22
Traded 24/08/21
J. Matthew SingletonDirector
Sell10b5-1 planViking Therapeutics
Sell10b5-1 plan
Viking Therapeutics
VKTX
$278.9K
4,509 sh
$278.9K
Filed 24/08/19
Traded 24/08/19
J. Matthew SingletonDirector
Sell10b5-1 planViking Therapeutics
Sell10b5-1 plan
Viking Therapeutics
VKTX
$186.3K
3,047 sh
$186.3K
Filed 24/08/19
Traded 24/08/19
J. Matthew SingletonDirector
Sell10b5-1 planViking Therapeutics
Sell10b5-1 plan
Viking Therapeutics
VKTX
$153.1K
2,388 sh
$153.1K
Filed 24/08/19
Traded 24/08/19